123 related articles for article (PubMed ID: 34774850)
21. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways.
Fu X; Feng J; Zeng D; Ding Y; Yu C; Yang B
Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919028
[TBL] [Abstract][Full Text] [Related]
22. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W
Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA PICART1 inhibits cell proliferation by regulating the PI3K/AKT and MAPK/ERK signaling pathways in gastric cancer.
Li JF; Li WH; Xue LL; Zhang Y
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):588-597. PubMed ID: 30720166
[TBL] [Abstract][Full Text] [Related]
24. NUCKS1 promotes gastric cancer cell aggressiveness by upregulating IGF-1R and subsequently activating the PI3K/Akt/mTOR signaling pathway.
Huang YK; Kang WM; Ma ZQ; Liu YQ; Zhou L; Yu JC
Carcinogenesis; 2019 Apr; 40(2):370-379. PubMed ID: 30371738
[TBL] [Abstract][Full Text] [Related]
25. Huachansu Capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway.
Ni T; Wang H; Li D; Tao L; Lv M; Jin F; Wang W; Feng J; Qian Y; Sunagawa M; Liu Y
Biomed Pharmacother; 2019 Oct; 118():109241. PubMed ID: 31351435
[TBL] [Abstract][Full Text] [Related]
26. The long noncoding RNA CRAL reverses cisplatin resistance via the miR-505/CYLD/AKT axis in human gastric cancer cells.
Wang Z; Wang Q; Xu G; Meng N; Huang X; Jiang Z; Chen C; Zhang Y; Chen J; Li A; Li N; Zou X; Zhou J; Ding Q; Wang S
RNA Biol; 2020 Nov; 17(11):1576-1589. PubMed ID: 31885317
[TBL] [Abstract][Full Text] [Related]
27. Polyphyllin I inhibits growth and invasion of cisplatin-resistant gastric cancer cells by partially inhibiting CIP2A/PP2A/Akt signaling axis.
Zhang Y; Huang P; Liu X; Xiang Y; Zhang T; Wu Y; Xu J; Sun Z; Zhen W; Zhang L; Si Y; Liu Y
J Pharmacol Sci; 2018 Jul; 137(3):305-312. PubMed ID: 30119963
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance.
Wu QN; Liao YF; Lu YX; Wang Y; Lu JH; Zeng ZL; Huang QT; Sheng H; Yun JP; Xie D; Ju HQ; Xu RH
Cancer Lett; 2018 Jan; 412():243-255. PubMed ID: 29050982
[TBL] [Abstract][Full Text] [Related]
29. RNF138 confers cisplatin resistance in gastric cancer cells via activating Chk1 signaling pathway.
Lu Y; Han D; Liu W; Huang R; Ou J; Chen X; Zhang X; Wang X; Li S; Wang L; Liu C; Miao S; Wang L; Ma C; Song W
Cancer Biol Ther; 2018; 19(12):1128-1138. PubMed ID: 30260263
[TBL] [Abstract][Full Text] [Related]
30. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
[TBL] [Abstract][Full Text] [Related]
31. TCF21 inhibits proliferation and chemoresistance through the AKT pathway in human gastric cancer.
Yang Z; Jiang X; Li D; Dong Q; Zhao H; Jiang X
Gene; 2019 Jan; 682():42-49. PubMed ID: 30296564
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of CD133 Overcomes Cisplatin Resistance Through Inhibiting PI3K/AKT/mTOR Signaling Pathway and Autophagy in CD133-Positive Gastric Cancer Cells.
Lu R; Zhao G; Yang Y; Jiang Z; Cai J; Hu H
Technol Cancer Res Treat; 2019 Jan; 18():1533033819864311. PubMed ID: 31405336
[TBL] [Abstract][Full Text] [Related]
33. Neogenin-1 Promotes Cell Proliferation, Motility, and Adhesion by Up-Regulation of Zinc Finger E-Box Binding Homeobox 1 Via Activating the Rac1/PI3K/AKT Pathway in Gastric Cancer Cells.
Qu H; Sun H; Wang X
Cell Physiol Biochem; 2018; 48(4):1457-1467. PubMed ID: 30064133
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-95-3p serves as a contributor to cisplatin resistance in human gastric cancer cells by targeting EMP1/PI3K/AKT signaling.
Ni Q; Zhang Y; Tao R; Li X; Zhu J
Aging (Albany NY); 2021 Mar; 13(6):8665-8687. PubMed ID: 33714198
[TBL] [Abstract][Full Text] [Related]
35. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
36. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of integrin subunit alpha 11 restrains gastric cancer progression through phosphatidylinositol 3-kinase/Akt pathway.
Zhang H; Zhang L; Lu M
Bioengineered; 2021 Dec; 12(2):11909-11921. PubMed ID: 34802381
[TBL] [Abstract][Full Text] [Related]
38. Cisplatin resistance in lung cancer is mediated by MACC1 expression through PI3K/AKT signaling pathway activation.
Zhang Q; Zhang B; Sun L; Yan Q; Zhang Y; Zhang Z; Su Y; Wang C
Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):748-756. PubMed ID: 29961813
[TBL] [Abstract][Full Text] [Related]
39. ATXN2L upregulated by epidermal growth factor promotes gastric cancer cell invasiveness and oxaliplatin resistance.
Lin L; Li X; Pan C; Lin W; Shao R; Liu Y; Zhang J; Luo Y; Qian K; Shi M; Bin J; Liao Y; Liao W
Cell Death Dis; 2019 Feb; 10(3):173. PubMed ID: 30787271
[TBL] [Abstract][Full Text] [Related]
40. PEA‑15 contributes to the clinicopathology and AKT‑regulated cisplatin resistance in gastric cancer.
Jiang X; Zhang C; Li W; Jiang D; Wei Z; Lv M; Xie X; Sun X
Oncol Rep; 2019 Mar; 41(3):1949-1959. PubMed ID: 30569123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
